Image Credit: STAT News
STAT+: Pharmalittle: We’re reading about J&J building U.S. plants, a weight loss-drug race in India, and more
J&J plans to spend over $55 billion to build four plants in the U.S. as the Trump administration pressures companies to expand manufacturing domestically